3,5-Diiodotyrosine

DB03374ExperimentalSmall molecule

A product from the iodination of MONOIODOTYROSINE. In the biosynthesis of thyroid hormones, diiodotyrosine residues are coupled with other monoiodotyrosine or diiodotyrosine residues to form T4 or T3 thyroid hormones...

Formula / weight: C₉H₉I₂NO₃ · 432.9816 g/mol (avg)

Resolves to

Compound

UNII6L57Q44ZWWCAS300-39-0ChEMBLCHEMBL1236469ChEBI15768PubChem9305KEGGC01060

Structure

InChIKeyNYPYHUZRZVSYKL-ZETCQYMHSA-NSMILES[H][C@](N)(CC1=CC(I)=C(O)C(I)=C1)C(O)=O

Targets

P61925PKIAP17612PRKACAQ9KFR4Alpha-amylase G-6P07477PRSS1P33590nikAQ6PHW0IYD

What you can answer from here — as of September 13, 2026

6Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

358Drug interactionsStructured to mechanism, not free text

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with 3,5-Diiodotyrosine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account